These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Nonrheumatic Atrial Fibrillation. Sick PB J Atr Fibrillation; 2013; 6(3):923. PubMed ID: 28496896 [No Abstract] [Full Text] [Related]
11. WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation: a percutaneous-device delivery approach. Lerakis S; Synetos A Future Cardiol; 2007 Sep; 3(5):507-9. PubMed ID: 19804304 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility. Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous devices for left atrial appendage occlusion: A contemporary review. Moussa Pacha H; Al-Khadra Y; Soud M; Darmoch F; Moussa Pacha A; Alraies MC World J Cardiol; 2019 Feb; 11(2):57-70. PubMed ID: 30820276 [TBL] [Abstract][Full Text] [Related]
14. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN. Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes. Park JW; Leithäuser B; Gerk U; Vrsansky M; Jung F J Invasive Cardiol; 2009 Sep; 21(9):446-50. PubMed ID: 19726815 [TBL] [Abstract][Full Text] [Related]
17. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159 [TBL] [Abstract][Full Text] [Related]
18. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation. Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585 [TBL] [Abstract][Full Text] [Related]